Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Traboulsee

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Vaccine|September 20, 2011
Acute disseminated encephalomyelitis following influenza vaccinationA Shoamanesh, A Traboulsee
BMC Neurology|April 23, 2008
Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) studyA Traboulsee, A Al-Sabbagh, R Bennett, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2011
The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosisR C Tam, A Traboulsee, A Riddehough, et al.
AJNR. American Journal of Neuroradiology|October 10, 2015
FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion DetectionV Wiggermann, E Hernández-Torres, A Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Does MRI lesion activity regress in secondary progressive multiple sclerosis?Y Zhao, A J Petkau, A Traboulsee, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 26, 2017
Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trialsA Traboulsee, Dkb Li, R Tam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2013
Labor induction and augmentation in women with multiple sclerosisE Lu, F Zhu, Ml van der Kop, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trialL M Metz, D Li, A Traboulsee, et al.
Neurology|November 19, 2011
Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosisC A Riddell, Y Zhao, D K B Li, et al.
Journal of the Neurological Sciences|September 30, 2008
Longitudinal changes in myelin water fraction in two MS patients with active diseaseI M Vavasour, C Laule, D K B Li, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Vaccine|September 20, 2011
Acute disseminated encephalomyelitis following influenza vaccinationA Shoamanesh, A Traboulsee
BMC Neurology|April 23, 2008
Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) studyA Traboulsee, A Al-Sabbagh, R Bennett, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2011
The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosisR C Tam, A Traboulsee, A Riddehough, et al.
AJNR. American Journal of Neuroradiology|October 10, 2015
FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion DetectionV Wiggermann, E Hernández-Torres, A Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Does MRI lesion activity regress in secondary progressive multiple sclerosis?Y Zhao, A J Petkau, A Traboulsee, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 26, 2017
Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trialsA Traboulsee, Dkb Li, R Tam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2013
Labor induction and augmentation in women with multiple sclerosisE Lu, F Zhu, Ml van der Kop, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trialL M Metz, D Li, A Traboulsee, et al.
Neurology|November 19, 2011
Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosisC A Riddell, Y Zhao, D K B Li, et al.
Journal of the Neurological Sciences|September 30, 2008
Longitudinal changes in myelin water fraction in two MS patients with active diseaseI M Vavasour, C Laule, D K B Li, et al.
Pageof 3